65185-57-1

Basic information

• Product Name: N-(2-(2-Bromophenyl)ethyl)-N-(phenylmethyl)amine
• Synonyms: N-(2-(2-Bromophenyl)ethyl)-N-(phenylmethyl)amine
• CAS NO: 65185-57-1
• Molecular Weight: 290.203
• Mol File: 65185-57-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-(2-(2-Bromophenyl)ethyl)-N-(phenylmethyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-(2-Bromophenyl)ethyl)-N-(phenylmethyl)amine(65185-57-1)
• EPA Substance Registry System: N-(2-(2-Bromophenyl)ethyl)-N-(phenylmethyl)amine(65185-57-1)

Safety Data

• Hazardous Substances Data: 65185-57-1(Hazardous Substances Data)

Upstream product

• 1074-16-4 2-bromophenylethyl alcohol 
• 2183-83-7 methanesulfonic acid 2-(2-bromophenyl)ethyl ester 
• 100-46-9 benzylamine 
• 1093413-22-9 C₂₁H₁₉BrN₂O₄S 
• 178809-24-0 (ortho-bromophenylacetyl)benzylamine 
• 65185-68-4 o-bromonitrostyrene 
• 65185-58-2 2-(2-bromophenyl)ethanamine 
• 26260-02-6 2-iodobenzaldehyde 
• 100-52-7 benzaldehyde 
• 97456-85-4 [2-(2-Bromo-phenyl)-ethyl]-(2-iodo-benzyl)-amine; hydrochloride 

Downstream Products

• 6037-73-6 1-benzyl-2,3-dihydro-1H-indole 
• 1109229-94-8 methyl benzyl[2-(2-bromophenyl)ethyl]carbamate 
• 1109229-95-9 2-benzyl-5-bromo-3,4-dihydroisoquinolin-1(2H)-one 
• 1109229-96-0 2-benzyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxylic acid 
• 1109229-92-6 2-benzyl-N-[(1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-3-({1-[3-(trifluoromethyl)phenyl]cyclopropyl}amino)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide 
• 1109229-97-1 2-benzyl-N-[(1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-3-({1-[3-(trifluoromethyl)phenyl]cyclopropyl}amino)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide hydrochloride 

Relevant articles and documents

1-OXO-ISOINDOLINE-4-CARBOXAMIDE AND 1-OXO-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

The present invention relates to derivatives of 1-oxo-isoindoline-4-carboxamides and of 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamides, to the preparation thereof and to the therapeutic use thereof.

Fused cycloheptane and fused azacycloheptane compounds and their methods of use

The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as αvβ3, αvβ5, αvβ6and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.